Acute treatment and rapid treatment of headache using anti-CGRP antibodies
US12215144B2 · kind B2 · utility
0Cited by
40References
31Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 19, 2024 |
| Grant date | Feb 4, 2025 |
| Priority date | — |
| Expiry date | Mar 19, 2044 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/76
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Methods for rapid treatment of chronic migraine are provided. Exemplary methods provide relief from migraine within 24 hours of administration. Also provided are methods for acute treatment of migraine. Exemplary methods comprise administration of an anti-CGRP antagonist antibody to a patient in need thereof.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.